Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Other Working Capital Changes (2018 - 2025)

AdaptHealth (AHCO) has 8 years of Other Working Capital Changes data on record, last reported at -$106.2 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 1044.38% year-over-year to -$106.2 million; the TTM value through Dec 2025 reached -$31.1 million, up 5.52%, while the annual FY2025 figure was -$31.1 million, 5.52% up from the prior year.
  • Other Working Capital Changes reached -$106.2 million in Q4 2025 per AHCO's latest filing, down from $90.9 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $90.9 million in Q3 2025 and bottomed at -$106.2 million in Q4 2025.
  • Average Other Working Capital Changes over 5 years is -$3.9 million, with a median of -$7.4 million recorded in 2022.
  • Peak YoY movement for Other Working Capital Changes: plummeted 4161.11% in 2021, then soared 1322.86% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at $20.6 million in 2021, then plummeted by 170.13% to -$14.4 million in 2022, then soared by 238.39% to $20.0 million in 2023, then tumbled by 146.49% to -$9.3 million in 2024, then plummeted by 1044.38% to -$106.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$106.2 million in Q4 2025, $90.9 million in Q3 2025, and -$15.6 million in Q2 2025.